Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Real World Effectiveness of Beclomethasone Dipropionate (BDP) Nasal Aerosol in Perennial Allergic Rhinitis (PAR) Patients

NCT01632540 is registered in ClinicalTrials.gov with Teva Branded Pharmaceutical Products R&D, Inc. as lead sponsor.

NCT NCT01632540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01632540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Real World Effectiveness of Beclomethasone Dipropionate (BDP) Nasal Aerosol in Perennial Allergic Rhinitis (PAR) Patients
Lead sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Phase
Observational
Overall status
Completed
Start date
July 31, 2012
Completion date
February 28, 2014
Enrollment
824 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

perennial allergic rhinitis (par)